Efficacy of a medical grade honey formulation (L-Mesitran) in comparison with fluconazole in the treatment of women with recurrent vulvovaginal candidiasis: protocol for a randomised controlled trial (HONEY STUDY)

INTRODUCTION: Recurrent vulvovaginal candidiasis (RVVC) affects up to 9% of women worldwide. This amount is expected to increase due to lifestyle changes, increased fungal resistance and biofilm formation. Treatment options are limited and in 57% of the cases, relapses occur within 12 months after s...

Descripción completa

Detalles Bibliográficos
Autores principales: van Riel, Senna J J M, Lardenoije, Céline M J G, Wassen, Martine M L H, van Kuijk, Sander M J, Cremers, Niels A J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Obstetrics and Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462966/
https://www.ncbi.nlm.nih.gov/pubmed/37640455
http://dx.doi.org/10.1136/bmjopen-2022-070466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462966/
https://www.ncbi.nlm.nih.gov/pubmed/37640455
http://dx.doi.org/10.1136/bmjopen-2022-070466

Ejemplares similares